Search Results - "Nassour, Lauren C."

Abstract 4668: In-vitro modeling of tumor-associated macrophages in glioblastoma by Alrefai, Hasan, Beierle, Andee M., Schanel, Taylor L., Nassour, Lauren C., Anderson, Joshua C., Hicks, Patricia H., Willey, Christopher D.

“…Abstract BACKGROUND: The Glioblastoma (GBM) tumor microenvironment (TME) is comprised of a plethora of cancerous and non-cancerous cells that contribute to GBM…”
Get full text

Abstract 3568: Developing pediatric glioblastoma microtumors with a three-dimensional bioprinter by Beierle, Andee M., Schanel, Taylor L., Alrefai, Hasan, Anderson, Joshua C., Hicks, Patricia H., Nassour, Lauren C., Willey, Christopher D.

“…Abstract Background:Glioblastoma multiforme is one of the most devastating forms of brain cancer seen in children. Children diagnosed with high-grade gliomas…”
Get full text

Abstract 1102: Establishing the cytotoxic benefit of Tumor Treating Fields on radiation sensitive and acquired radiation resistant glioblastoma patient derived xenograft pairs by Schanel, Taylor L., Jones, Amber B., Beierle, Andee M., Alrefai, Hasan, Nassour, Lauren C., Hicks, Patricia H., Anderson, Joshua C., Hjelmeland, Anita B., Willey, Christopher D.

“…Abstract Background: Glioblastoma (GBM) is the most common malignant primary brain tumor with very poor prognosis. The current standard of care for GBM…”
Get full text

Abstract 1273: Glioblastoma brain tumor-initiating cells are protected from hypoxia when co-cultured with normal human astrocytes revealing a potential role for mitochondrial transfer via tunneling nanotubes by Nassour-Caswell, Lauren C., Eustace, Nicholas J., Stackhouse, Christian T., Alrefai, Hasan, Hicks, Patricia H., Schanel, Taylor L., Anderson, Joshua C., Beierle, Andee M., Willey, Christopher D.

“…Abstract Background: Glioblastoma (GBM) has a median survival of <2 years and generally recurs within 6 months of treatment due to the development of chemo-…”
Get full text

Abstract 3360: Myristoylated alanine-rich C-kinase substrate (MARCKS) as a target for pathological tunneling nanotubes in glioblastoma by Nassour-Caswell, Lauren C., Eustace, Nicholas J., Rich-New, Shane T., Schanel, Taylor L., Alrefai, Hasan, Beierle, Andee M., Kumar, Manoj, Hicks, Patricia H., Anderson, Johsua C., Willey, Christopher D.

“…Abstract Background: Glioblastoma (GBM) is a lethal brain malignancy with a median survival of <2 years due to relapse in 100% of cases. Tunneling nanotubes…”
Get full text